Abstract:Hydrogels are versatile materials that have emerged in the last few decades as promising candidates for a range of applications in the biomedical field, from tissue engineering and regenerative medicine to controlled drug delivery. In the drug delivery field, in particular, they have been the subject of significant interest for the spatially and temporally controlled delivery of anticancer drugs and therapeutics. Self-assembling peptide-based hydrogels, in particular, have recently come to the fore as potential candidate vehicles for the delivery of a range of drugs. In order to explore how drug-peptide interactions influence doxorubicin (Dox) release, five β-sheet-forming self-assembling peptides with different physicochemical properties were used for the purpose of this study, namely: FEFKFEFK (F8), FKFEFKFK (FK), FEFEFKFE (FE), FEFKFEFKK (F8K), and KFEFKFEFKK (KF8K) (F: phenylalanine; E: glutamic acid; K: lysine). First, Dox-loaded hydrogels were characterized to ensure that the incorporation of the drug did not significantly affect the hydrogel properties. Subsequently, Dox diffusion out of the hydrogels was investigated using UV absorbance. The amount of drug retained in F8/FE composite hydrogels was found to be directly proportional to the amount of charge carried by the peptide fibers. When cation-π interactions were used, the position and number of end-lysine were found to play a key role in the retention of Dox. In this case, the amount of Dox retained in F8/KF8K composite hydrogels was linked to the amount of end-lysine introduced, and an end-lysine/Dox interaction stoichiometry of 3/1 was obtained. For pure FE and KF8K hydrogels, the maximum amount of Dox retained was also found to be related to the overall concentration of the hydrogels and, therefore, to the overall fiber surface area available for interaction with the drug. For 14 mM hydrogel, ∼170-200 μM Dox could be retained after 24 h. This set of peptides also showed a broad range of susceptibilities to enzymatic degradation opening the prospect of being able to control also the rate of degradation of these hydrogels. Finally, the Dox released from the hydrogel was shown to be active and affect 3T3 mouse fibroblasts viability in vitro. Our study clearly shows the potential of this peptide design as a platform for the formulation of injectable or sprayable hydrogels for controlled drug delivery.

Tuning the drug multimodal release through a co-assembly strategy based on magnetic gels

Peptide-Based Hydrogels and Nanogels for Delivery of Doxorubicin

An Injectable Composite Co‐Assembled Dehydropeptide‐Based Magnetic/Plasmonic Lipogel for Multimodal Cancer Therapy

Long-term doxorubicin release from multiple stimuli-responsive hydrogels based on α-amino-acid residues

Magnetically Controllable Polymer Nanotubes from a Cyclized Crosslinker for Site-Specific Delivery of Doxorubicin

Controlling Doxorubicin Release from a Peptide Hydrogel through Fine-Tuning of Drug–Peptide Fiber Interactions

A hyperbranched amphiphilic acetal polymer for pH-sensitive drug delivery

Molecular design of peptide amphiphiles for controlled self-assembly and drug release

New Supramolecular Hydrogels Based on Diastereomeric Dehydrotripeptide Mixtures for Potential Drug Delivery Applications

Stimuli‐Responsive Nucleic Acid‐Based Polyacrylamide Hydrogel‐Coated Metal–Organic Framework Nanoparticles for Controlled Drug Release

Doxorubicin-reinforced Supramolecular Hydrogels of RGD-derived Peptide Conjugates for Ph-Responsive Drug Delivery

Injectable Supramolecular Hydrogels Fabricated From Pegylated Doxorubicin Prodrug And Alpha-Cyclodextrin For Ph-Triggered Drug Delivery

Injectable supramolecular hydrogels fabricated from PEGylated doxorubicin prodrug and α-cyclodextrin for pH-triggered drug delivery

In situ self-assembly of gold nanorods with thermal-responsive microgel for multi-synergistic remote drug delivery

Swollen Micelles for the Preparation of Gated, Squeezable, Ph-Responsive Drug Carriers.

Tailoring Co-Assembly Loading of Doxorubicin in Solvent-Triggering Gel.

A Facile Strategy For In Situ Controlled Delivery Of Doxorubicin With A Ph-Sensitive Injectable Hydrogel

Ph-Triggered Doxorubicin Delivery Based on Hollow Nanoporous Silica Nanoparticles with Free-Standing Superparamagnetic Fe3O4 Cores

Sequential thermo-induced self-gelation and acid-triggered self-release process of drug-conjugated nanoparticles: A strategy for the sustained and controlled drug delivery to tumors

Bioinspired Coordination Micelles Integrating High Stability, Triggered Cargo Release, and Magnetic Resonance Imaging

A co-assembly process for a high strength and injectable dual network gel with sustained doxorubicin release performance